Keyphrases
Ovarian Cancer
80%
Epithelial Ovarian Cancer
50%
Tumor
41%
Ovarian Cancer Risk
35%
Breast Cancer
31%
Confidence Interval
30%
Colorectal Cancer
27%
Overall Survival
27%
Breast Cancer Patients
25%
Denmark
22%
Ovarian Cancer Patients
21%
Cancer Association
21%
Hazard Ratio
18%
Ulcerative Colitis
17%
MicroRNA
17%
Prognostic Value
14%
Inflammatory Bowel Disease
14%
Tumor Tissue
14%
Immunohistochemistry
13%
Metastatic Colorectal Cancer (mCRC)
13%
Tumor-infiltrating Lymphocytes
12%
Melanoma
12%
Chemotherapy
11%
Programmed Death-ligand 1 (PD-L1)
11%
Pooled Analysis
10%
Breast Cancer Risk
10%
Odds Ratio
10%
Histological Subtypes
10%
Prostate Cancer
10%
Crohn's Disease
10%
Irinotecan
10%
Progression-free Survival
9%
Human Epidermal Growth Factor Receptor 2 (HER2)
9%
High-risk Human Papillomavirus (HR-HPV)
9%
YKL-40
9%
Endometrial Cancer
9%
High Risk
9%
Sentinel Lymph Node
9%
Next-generation Sequencing
9%
Ovarian Carcinoma
8%
Metastasis
8%
Colon Cancer
8%
Cancer Patients
8%
Prognostic Factors
8%
SNP
8%
Carbohydrate Antigen 125 (CA125)
7%
Cyclophosphamide
7%
Multiparametric MRI (mpMRI)
7%
B-cell Lymphoma 2 (Bcl-2)
7%
Ovarian Tumor
7%
Quantitative PCR
7%
Risk Factors
7%
National Cohort Study
7%
Genome-wide Association Study
7%
Susceptibility Loci
7%
Estrogen Receptor
7%
In Cancer
7%
Breast
7%
Primary Tumor
7%
KRAS mutation
6%
Diffuse Large B-cell Lymphoma (DLBCL)
6%
Triple-negative Breast Cancer
6%
Ovarian Cancer Survival
6%
Advanced Breast Cancer
6%
Pelvic Mass
6%
Disease-free Survival
6%
Cervical Cancer
6%
Single nucleotide Polymorphism
6%
Cetuximab
6%
Randomized Trial
6%
Cancer Cases
6%
Clinical Outcomes
6%
Blood Samples
6%
Predictive Value
6%
Protein Expression
6%
Gynecological Cancer
6%
Cancer Risk
6%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
6%
Tissue Sampling
6%
Lymphoma
5%
Topoisomerase
5%
Gemcitabine
5%
Cooperative Group
5%
Docetaxel
5%
Pathologist
5%
T Cells
5%
Colonoscopy
5%
High-grade Serous Ovarian Cancer (HGSOC)
5%
Recurrence Risk
5%
Magnetic Resonance Imaging
5%
Expression Level
5%
Early Breast Cancer
5%
Colorectal Cancer Screening
5%
Tumor Cells
5%
Prognostic Marker
5%
Pancreatic Cyst
5%
Postmenopausal Women
5%
Gene Expression
5%
Tissue Analysis
5%
Formalin-fixed Paraffin-embedded Tissue
5%
Medicine and Dentistry
Ovarian Cancer
100%
Neoplasm
82%
Breast Cancer
55%
Krukenberg Tumor
47%
Malignant Neoplasm
36%
Biological Marker
32%
Diagnosis
28%
Biopsy
25%
Overall Survival
24%
Disease
24%
Colorectal Cancer
23%
Recurrent Disease
16%
Ulcerative Colitis
15%
Cancer Risk
15%
Colon Cancer
14%
Nodular Melanoma
14%
Magnetic Resonance Imaging
14%
Ovarian Tumor
14%
Hazard Ratio
14%
microRNA
13%
Immunohistochemistry
13%
Cohort Analysis
13%
Tumor Infiltrating Lymphocyte
13%
Metastatic Carcinoma
12%
Estrogen Receptor
12%
Prostate Cancer
12%
Cancer
11%
Single Nucleotide Polymorphism
11%
Next Generation Sequencing
10%
Inflammatory Bowel Disease
10%
Wart Virus
10%
Pooled Analysis
10%
Progression Free Survival
9%
Adenocarcinoma
9%
Endometrial Cancer
9%
Sentinel Node
9%
Prevalence
8%
Systematic Review
8%
Odds Ratio
8%
Surgery
8%
Tumor Cell
8%
T Cell
8%
Case-Control Study
7%
Lymph Node Metastasis
7%
Genome Wide Association Study
7%
Colonoscopy
7%
Pelvis
7%
Cancer Susceptibility
6%
Prognostic Factor
6%
Protein Expression
6%
CA-125
6%
Gene Expression
6%
Metastatic Colorectal Cancer
6%
Histopathology
6%
Lymph Node
6%
Diffuse Large B-Cell Lymphoma
6%
Pathologist
6%
Primary Tumor
6%
Triple Negative Breast Cancer
6%
Proportional Hazards Model
5%
Disease Free Survival
5%
DNA Mismatch Repair
5%
Clinical Trial
5%
Retroperitoneal Lymph Node Dissection
5%
Female Genital Tract Cancer
5%
Tamoxifen
5%
Immunoglobulin
5%
Reproducibility
5%
Colon
5%
Adverse Event
5%
Positron Emission Tomography-Computed Tomography
5%
Colorectal Cancer Screening
5%
Needle Biopsy
5%
Crohn's Disease
5%
Interstitial Cell
5%
Hormone Receptor
5%
Allele
5%
In Vitro
5%
Large-Cell Lymphoma
5%